Teva Pharm expects to start paying U.S. opioid settlement in 2023 - CEO
Teva, denying 'any liability,' set aside $646M for opioid settlements. Here's why | Fierce Pharma
What To Do After TEVA Stock Falls Below $10 Again (NYSE:TEVA) | Seeking Alpha
How Teva Pharmaceutical is managing third-party risk better | EY - Global
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/QLOB6IH57ZGW3NM55HWQDLO2BU.jpg "Teva Pharmaceutical Industries names a new CEO")
Teva Pharmaceutical Industries names a new CEO
Teva cleared in French switched drug packaging investigation - Jewish Business News
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva fueled opioid addiction in New York state, jury finds | Business and Economy News | Al Jazeera
Teva Pharmaceutical, Owner of Frazer's Cephalon, Forms Joint Venture With Japanese Drug Firm
Teva settles with Oklahoma for $85 million in opioid case | The Times of Israel
Rhode Island takes Teva to trial in multibillion-dollar opioid case | Reuters
Teva shares surge after announcing global opioid settlement
TEVA Pharmaceuticals sells Forest facility to private investor | WSET
New York court dismisses most of Teva claims against Mexican drugmakers | The Times of Israel
What's Next For Teva Pharmaceutical Stock After A 17% Fall In A Month?
Teva Pharmaceuticals Sterile Manufacturing Facility, Ulm - Pharmaceutical Technology
Generics distributor Anda, Inc. has a new owner: Teva Pharma
Teva generic medicines hi-res stock photography and images - Alamy
DEF 14A
As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech
Teva Pharmaceutical in $4.35 opioid settlement with states, Native American tribes (TEVA) | Seeking Alpha
Definitive Proxy Statement
Teva Pharmaceutical Industries Limited's (NYSE:TEVA) recent 9.3% pullback adds to one-year year losses, institutional owners may take drastic measures | Nasdaq
